Eagle Pharmaceuticals Stock Price History
| EGRX Stock | USD 4.77 0.22 4.84% |
Below is the normalized historical share price chart for Eagle Pharmaceuticals extending back to February 12, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eagle Pharmaceuticals stands at 4.77, as last reported on the 25th of April, with the highest price reaching 5.01 and the lowest price hitting 4.54 during the day.
If you're considering investing in Eagle Stock, it is important to understand the factors that can impact its price. Eagle Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0272, which denotes the company had a -0.0272% return per unit of risk over the last 3 months. Eagle Pharmaceuticals exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eagle Pharmaceuticals' Coefficient Of Variation of 2276.85, mean deviation of 4.17, and Downside Deviation of 5.13 to check the risk estimate we provide.
At this time, Eagle Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Stock Based Compensation To Revenue is likely to rise to 0.06 in 2024, whereas Total Stockholder Equity is likely to drop slightly above 138 M in 2024. . At this time, Eagle Pharmaceuticals' Price To Operating Cash Flows Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 7.07 in 2024, whereas Price To Sales Ratio is likely to drop 1.30 in 2024. Eagle Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of February 2014 | 200 Day MA 10.3853 | 50 Day MA 5.4514 | Beta 0.409 |
Eagle |
Sharpe Ratio = -0.0272
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | EGRX |
Estimated Market Risk
| 5.26 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Eagle Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eagle Pharmaceuticals by adding Eagle Pharmaceuticals to a well-diversified portfolio.
Price Book 0.236 | Enterprise Value Ebitda 2.0711 | Price Sales 0.2309 | Shares Float 10.4 M | Wall Street Target Price 17 |
Eagle Pharmaceuticals Stock Price History Chart
There are several ways to analyze Eagle Stock price data. The simplest method is using a basic Eagle candlestick price chart, which shows Eagle Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 5, 2024 | 6.51 |
| Lowest Price | April 17, 2024 | 4.39 |
Eagle Pharmaceuticals April 25, 2024 Stock Price Synopsis
Various analyses of Eagle Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eagle Stock. It can be used to describe the percentage change in the price of Eagle Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eagle Stock.| Eagle Pharmaceuticals Price Rate Of Daily Change | 1.05 | |
| Eagle Pharmaceuticals Price Daily Balance Of Power | 0.47 | |
| Eagle Pharmaceuticals Price Action Indicator | 0.10 |
Eagle Pharmaceuticals April 25, 2024 Stock Price Analysis
Eagle Stock Price History Data
The price series of Eagle Pharmaceuticals for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 2.12 with a coefficient of variation of 11.4. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.42. The median price for the last 90 days is 5.32.| Open | High | Low | Close | Volume | ||
04/25/2024 | 4.57 | 5.01 | 4.54 | 4.77 | ||
| 04/23/2024 | 4.57 | 5.01 | 4.54 | 4.77 | 88,216 | |
| 04/22/2024 | 4.60 | 4.81 | 4.51 | 4.55 | 283,208 | |
| 04/19/2024 | 4.48 | 4.74 | 4.48 | 4.61 | 59,516 | |
| 04/18/2024 | 4.36 | 4.75 | 4.36 | 4.48 | 135,741 | |
| 04/17/2024 | 4.69 | 4.77 | 4.37 | 4.39 | 109,204 | |
| 04/16/2024 | 5.20 | 5.20 | 4.57 | 4.69 | 161,336 | |
| 04/15/2024 | 4.40 | 5.26 | 4.28 | 5.20 | 380,164 | |
| 04/12/2024 | 4.79 | 4.81 | 4.57 | 4.59 | 130,963 | |
| 04/11/2024 | 4.70 | 4.81 | 4.56 | 4.77 | 102,479 | |
| 04/10/2024 | 4.88 | 4.88 | 4.60 | 4.70 | 114,324 | |
| 04/09/2024 | 4.96 | 5.05 | 4.87 | 4.95 | 78,526 | |
| 04/08/2024 | 5.15 | 5.26 | 4.84 | 5.00 | 90,425 | |
| 04/05/2024 | 5.20 | 5.20 | 4.99 | 5.12 | 144,722 | |
| 04/04/2024 | 4.92 | 5.27 | 4.92 | 5.21 | 98,162 | |
| 04/03/2024 | 4.43 | 4.95 | 4.41 | 4.86 | 689,091 | |
| 04/02/2024 | 4.77 | 4.77 | 4.46 | 4.50 | 133,182 | |
| 04/01/2024 | 5.40 | 5.40 | 4.73 | 4.77 | 173,849 | |
| 03/28/2024 | 4.96 | 5.37 | 4.96 | 5.24 | 80,453 | |
| 03/27/2024 | 5.12 | 5.12 | 4.91 | 5.01 | 100,867 | |
| 03/26/2024 | 5.15 | 5.19 | 5.02 | 5.04 | 51,545 | |
| 03/25/2024 | 5.11 | 5.23 | 4.93 | 5.08 | 129,342 | |
| 03/22/2024 | 5.21 | 5.25 | 4.90 | 5.05 | 159,415 | |
| 03/21/2024 | 5.73 | 5.82 | 5.23 | 5.23 | 105,056 | |
| 03/20/2024 | 5.51 | 5.77 | 5.39 | 5.68 | 99,517 | |
| 03/19/2024 | 5.59 | 5.68 | 5.20 | 5.50 | 183,207 | |
| 03/18/2024 | 5.95 | 6.19 | 5.54 | 5.62 | 144,807 | |
| 03/15/2024 | 5.96 | 6.13 | 5.72 | 6.05 | 333,544 | |
| 03/14/2024 | 6.08 | 6.09 | 5.78 | 5.95 | 102,500 | |
| 03/13/2024 | 5.78 | 6.17 | 5.78 | 6.01 | 78,657 | |
| 03/12/2024 | 5.94 | 5.94 | 5.58 | 5.73 | 153,618 | |
| 03/11/2024 | 6.06 | 6.20 | 5.73 | 5.87 | 124,565 | |
| 03/08/2024 | 6.28 | 6.50 | 6.24 | 6.25 | 73,784 | |
| 03/07/2024 | 6.30 | 6.40 | 6.05 | 6.25 | 88,434 | |
| 03/06/2024 | 6.60 | 6.74 | 6.22 | 6.35 | 63,815 | |
| 03/05/2024 | 6.31 | 6.65 | 6.31 | 6.51 | 117,107 | |
| 03/04/2024 | 6.70 | 6.70 | 6.13 | 6.29 | 128,501 | |
| 03/01/2024 | 5.89 | 6.81 | 5.87 | 6.48 | 188,269 | |
| 02/29/2024 | 6.26 | 6.44 | 5.73 | 5.86 | 154,847 | |
| 02/28/2024 | 6.43 | 6.45 | 6.16 | 6.27 | 99,589 | |
| 02/27/2024 | 6.50 | 6.65 | 6.23 | 6.44 | 113,274 | |
| 02/26/2024 | 6.24 | 6.54 | 6.16 | 6.48 | 134,242 | |
| 02/23/2024 | 5.85 | 6.32 | 5.75 | 6.25 | 166,785 | |
| 02/22/2024 | 6.16 | 6.24 | 5.86 | 5.87 | 120,517 | |
| 02/21/2024 | 5.94 | 6.43 | 5.93 | 6.23 | 125,367 | |
| 02/20/2024 | 5.91 | 6.09 | 5.80 | 5.99 | 256,844 | |
| 02/16/2024 | 5.84 | 6.13 | 5.80 | 5.97 | 157,357 | |
| 02/15/2024 | 5.23 | 5.85 | 5.21 | 5.85 | 207,076 | |
| 02/14/2024 | 5.39 | 5.39 | 5.18 | 5.25 | 143,790 | |
| 02/13/2024 | 5.45 | 5.54 | 5.05 | 5.21 | 441,708 | |
| 02/12/2024 | 5.36 | 5.82 | 5.30 | 5.60 | 455,579 | |
| 02/09/2024 | 5.33 | 5.47 | 5.18 | 5.32 | 247,551 | |
| 02/08/2024 | 5.16 | 5.34 | 5.02 | 5.32 | 195,577 | |
| 02/07/2024 | 4.82 | 5.32 | 4.65 | 5.17 | 321,338 | |
| 02/06/2024 | 5.60 | 5.64 | 4.59 | 4.90 | 689,657 | |
| 02/05/2024 | 5.77 | 5.77 | 5.41 | 5.60 | 214,433 | |
| 02/02/2024 | 5.99 | 6.07 | 5.59 | 5.85 | 271,122 | |
| 02/01/2024 | 5.85 | 6.14 | 5.81 | 6.08 | 352,284 | |
| 01/31/2024 | 5.48 | 5.90 | 5.45 | 5.86 | 355,150 | |
| 01/30/2024 | 5.51 | 5.63 | 5.33 | 5.48 | 165,716 | |
| 01/29/2024 | 5.32 | 5.54 | 5.08 | 5.51 | 216,961 |
About Eagle Pharmaceuticals Stock history
Eagle Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eagle is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eagle Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eagle Pharmaceuticals stock prices may prove useful in developing a viable investing in Eagle Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 15 M | 14.9 M | |
| Net Income Applicable To Common Shares | 41 M | 24.6 M |
Eagle Pharmaceuticals Quarterly Net Working Capital |
|
Eagle Pharmaceuticals Stock Technical Analysis
Eagle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Eagle Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eagle Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eagle Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eagle to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0362 | |||
| Jensen Alpha | 0.2773 | |||
| Total Risk Alpha | (0.43) | |||
| Sortino Ratio | 0.0278 | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eagle Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Eagle Stock please use our How to Invest in Eagle Pharmaceuticals guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Eagle Stock analysis
When running Eagle Pharmaceuticals' price analysis, check to measure Eagle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eagle Pharmaceuticals is operating at the current time. Most of Eagle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eagle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eagle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eagle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Eagle Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eagle Pharmaceuticals. If investors know Eagle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eagle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.87) | Earnings Share 0.85 | Revenue Per Share 19.684 | Quarterly Revenue Growth (0.13) | Return On Assets 0.0663 |
The market value of Eagle Pharmaceuticals is measured differently than its book value, which is the value of Eagle that is recorded on the company's balance sheet. Investors also form their own opinion of Eagle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eagle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eagle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eagle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eagle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eagle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eagle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.